Article info

PDF
Extended report
Rituximab for IgG4-related disease: a prospective, open-label trial

Authors

  1. Correspondence to Dr John H Stone, Rheumatology Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; jhstone{at}partners.org
View Full Text

Citation

Carruthers MN, Topazian MD, Khosroshahi A, et al
Rituximab for IgG4-related disease: a prospective, open-label trial

Publication history

  • Received September 10, 2014
  • Revised December 26, 2014
  • Accepted January 6, 2015
  • First published February 9, 2015.
Online issue publication 
May 08, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.